About: http://data.cimple.eu/news-article/cfe896051d48c477c18d06bf11c5c023e93d0de56b04f292cb27d879

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/cfe896051d48c477c18d06bf11c5c023e93d0de56b04f292cb27d879 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The European Medicines Agency will hold a press conference on its findings over possible links between AstraZeneca's coronavirus vaccine and blood clots at 4pm (1400 GMT) on Wednesday, the Amsterdam-based regulator said. "EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Vaxzevria (formerly Covid-19 Vaccine AstraZeneca) relating to cases of thromboembolic events by EMA's safety committee," it said in a statement. EMA chief Emer Cooke and senior officials from the agency will take part in the press conference, which comes after several European countries suspended use of the vaccine for younger people over the issue. The agency said it was a "preliminary timing" and could change. A senior EMA official was quoted in Italian media on Tuesday as saying that there was a "clear" connection between the AstraZeneca jab and clots, and that the agency would announce it soon. "In my opinion, we can say it now, it is clear there is a link with the vaccine," EMA head of vaccine strategy Marco Cavaleri told Italy's Il Messaggero newspaper in an interview. "But we still do not know what causes this reaction." However the EMA said later on Tuesday it had "not yet reached a conclusion and the review is currently ongoing". The watchdog has so far said that the vaccine is safe and effective, and that the benefits of using it to prevent illness and death caused by Covid-19 outweigh the possible risks. Last week after a meeting of experts the EMA said it had not found any "specific risk factors" such as age, gender or a previous medical history of clotting disorders. dk/wdb
schema:headline	EMA press conference on AstraZeneca at 1400 GMT
schema:mentions	Italian language Medical history Thrombosis European Medicines Agency Jab AstraZeneca Italy Vaccine Coronavirus Coronavirus disease 2019 Specific risk Il Messaggero Venous thrombosis Emer Greenwich Mean Time
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-04-07 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	83 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software